Literature DB >> 7512366

Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors.

E Rodriguez1, J Houldsworth, V E Reuter, P Meltzer, J Zhang, J M Trent, G J Bosl, R S Chaganti.   

Abstract

The i(12p) chromosome has been shown to characterize more than 80% of male germ cell tumors (GCTs) and is an important diagnostic marker. Although recent cytogenetic analyses of GCTs have defined nonrandom chromosome abnormalities in these tumors, no attempt has so far been made to compare i(12p)-positive and -negative tumors in terms of their cytogenetic, histologic, and clinical features. During a 5-year period, we have ascertained 202 GCTs, of which 117 had clonally abnormal karyotypes. Among the latter, 91 had one or more copies of i(12p), whereas 26 lacked an i(12p). We report here the karyotypic analysis of these 26 i(12p)-negative GCTs. In this group, nonrandom sites of chromosomal rearrangements included 12p13 (9/26) and 1p11-q11 (5/26). Comparison of the cytogenetic features of i(12p)-negative tumors with i(12p)-positive tumors revealed the only significant difference to be rearrangements affecting 12p13 in the former (35%) as compared to their absence in the latter (3%). Hybridization of metaphase preparations of 9 i(12p)-negative tumors with a chromosome 12 painting probe and with a microdissected 12p painting probe revealed extra copies of chromosome 12 segments incorporated into marker chromosomes whose composition could not otherwise be resolved by banding analysis; all were shown to be derived from 12p. These data demonstrate that both i(12p)-negative and -positive groups are characterized by an increased copy number of 12p, which is consistent with a lack of significant clinical or biological difference between them. An increased 12p copy number thus is a specific aberration of significance to the development of germ cell tumors.

Entities:  

Mesh:

Year:  1993        PMID: 7512366     DOI: 10.1002/gcc.2870080405

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

Authors:  Katherine Amps; Peter W Andrews; George Anyfantis; Lyle Armstrong; Stuart Avery; Hossein Baharvand; Julie Baker; Duncan Baker; Maria B Munoz; Stephen Beil; Nissim Benvenisty; Dalit Ben-Yosef; Juan-Carlos Biancotti; Alexis Bosman; Romulo Martin Brena; Daniel Brison; Gunilla Caisander; María V Camarasa; Jieming Chen; Eric Chiao; Young Min Choi; Andre B H Choo; Daniel Collins; Alan Colman; Jeremy M Crook; George Q Daley; Anne Dalton; Paul A De Sousa; Chris Denning; Janet Downie; Petr Dvorak; Karen D Montgomery; Anis Feki; Angela Ford; Victoria Fox; Ana M Fraga; Tzvia Frumkin; Lin Ge; Paul J Gokhale; Tamar Golan-Lev; Hamid Gourabi; Michal Gropp; Guangxiu Lu; Ales Hampl; Katie Harron; Lyn Healy; Wishva Herath; Frida Holm; Outi Hovatta; Johan Hyllner; Maneesha S Inamdar; Astrid Kresentia Irwanto; Tetsuya Ishii; Marisa Jaconi; Ying Jin; Susan Kimber; Sergey Kiselev; Barbara B Knowles; Oded Kopper; Valeri Kukharenko; Anver Kuliev; Maria A Lagarkova; Peter W Laird; Majlinda Lako; Andrew L Laslett; Neta Lavon; Dong Ryul Lee; Jeoung Eun Lee; Chunliang Li; Linda S Lim; Tenneille E Ludwig; Yu Ma; Edna Maltby; Ileana Mateizel; Yoav Mayshar; Maria Mileikovsky; Stephen L Minger; Takamichi Miyazaki; Shin Yong Moon; Harry Moore; Christine Mummery; Andras Nagy; Norio Nakatsuji; Kavita Narwani; Steve K W Oh; Sun Kyung Oh; Cia Olson; Timo Otonkoski; Fei Pan; In-Hyun Park; Steve Pells; Martin F Pera; Lygia V Pereira; Ouyang Qi; Grace Selva Raj; Benjamin Reubinoff; Alan Robins; Paul Robson; Janet Rossant; Ghasem H Salekdeh; Thomas C Schulz; Karen Sermon; Jameelah Sheik Mohamed; Hui Shen; Eric Sherrer; Kuldip Sidhu; Shirani Sivarajah; Heli Skottman; Claudia Spits; Glyn N Stacey; Raimund Strehl; Nick Strelchenko; Hirofumi Suemori; Bowen Sun; Riitta Suuronen; Kazutoshi Takahashi; Timo Tuuri; Parvathy Venu; Yuri Verlinsky; Dorien Ward-van Oostwaard; Daniel J Weisenberger; Yue Wu; Shinya Yamanaka; Lorraine Young; Qi Zhou
Journal:  Nat Biotechnol       Date:  2011-11-27       Impact factor: 54.908

2.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

3.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

Review 4.  Molecular biology of testicular germ cell tumors.

Authors:  E Vilar; E Calvo; J Tabernero
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

Review 5.  Genomic instability in pluripotent stem cells: implications for clinical applications.

Authors:  Suzanne E Peterson; Jeanne F Loring
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

6.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

7.  Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.

Authors:  J Jenderny; E Köster; A Meyer; O Borchers; W Grote; D Harms; U Jänig
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

Review 8.  Chemotherapy for patients with poor prognosis germ cell tumors.

Authors:  Matthew J Riese; David J Vaughn
Journal:  World J Urol       Date:  2009-03-28       Impact factor: 4.226

Review 9.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

10.  Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.

Authors:  B Summersgill; H Goker; S Weber-Hall; R Huddart; A Horwich; J Shipley
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.